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Introduction
Since the beginning of time, mankind has always admired salmon.1 Salmon work
hard, persevere in the face of adversity, and brave terrible peril just to complete
seemingly pointless tasks. The salmon’s quixotic journey back to its birthplace is both
inspirational and the subject of allegory. However, mankind has also admired salmon for
more than simply its inspirational story. Instead, humanity has found a much more useful
quality in salmon: they are very nutritious. Families in the United States consume
284,000 metric tons of salmon annually2, which is close to two pounds per capita, second
only to shrimp and tuna for fish consumption.3
Unfortunately, salmon have been overfished, and their numbers in the wild have
been declining rapidly.4 Some might say that the best way to combat this problem would
be to change the way we fish, or to change our eating habits, or possibly to help the
salmon reproduce in some way. But those solutions are difficult?, and often they do not
yield huge success. Recently AquaBounty,5 an English biotechnology company, found

Orin S. Kerr, A Theory of Law, 16 GREEN BAG 2d 111 (2012).
University of Alaska Anchorage Institute of Social and Economic Research, Overview of US Salmon
Consumption,
http://www.iser.uaa.alaska.edu/Publications/greatsalmonrun/SalmonReport_Ch_8.pdf
3 AboutSeafood.com, Top 10 Consumed Seafoods, http://www.aboutseafood.com/about/aboutseafood/top-10-consumed-seafoods
4 George Kimbrell, Paige Tomaselli, A "Fisheye" Lens on the Technological Dilemma: The Specter of
Genetically Engineered Animals, 18 Animal L. 75, 77 (2011).
5 AquaBounty Technologies was originally incorporated in 1991 under the name A/F Protein, to
pursue the commercial development of antifreeze protein-based technology under license from the
University of California at Berkeley. Reorganized in 2000, it was divided into two separate entities:
A/F Protein, which retained the antifreeze protein technology; and, AquaBounty Farms, which
obtained the AquAdvantage® technology. This is the current organization of the company
AquaBounty Technologies, The Company, http://www.aquabounty.com/company/company-history292.aspx.
1
2
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another solution to this problem. Resolving to bring “together biological sciences and
molecular technology to enable an aquaculture industry capable of large-scale, efficient,
and environmentally sustainable production of high quality seafood,” AquaBounty’s
solution uses genetic modification to create a completely new salmon from scratch,
infused with genetic abnormalities from two other fish. This newly created salmon, called
the AquAdvantage Salmon (AAS), grows to over four times the size of naturally
producing salmon, due to the genetic modification of AquaBounty in the zygote stage of
the salmon’s development.6
The zygote stage of development is the earliest developmental stage of complex,
or multi-celled organisms. This is an extremely critical part of the development of
complex organisms, because the zygote contains all the genetic information that will
define the organism for the rest of its life. Once solidified, this genetic blueprint will be
copied and divided into the millions of cells that make up complex organisms, such as
humans or salmon. The reason that this stage is extremely critical and highlighted in this
paper is because modification of the genetic structure during this stage of development
will forever change the genetic structure of the developing and adult organism. No further
human intervention would be necessary, because without anything further, all genetic
material would be copied and reproduced in the organism by the process of life itself.
The organism would live its life as normal, without needing constant human supervision
or upkeep.7

Matthew Morgan, The AquAdvantage Salmon: Who Owns Escaped Genetically Modified Animals?, 17
OCEAN & COASTAL L.J. 127, 128 (2011). How much of your paper mirrows this article??
7 In this specific case, scientists are modifying the zygote to add genetic material that they believe will
beneficial to salmon. Once altered, scientists do not need to do anything to accommodate the changes
that they have made in the salmon (aside from those societal and environmental ones discussed in
this note).
6
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AquaBounty accomplishes this genetic modification by taking a fertilized egg and
adding two genes from two different fish. The first gene comes from a Chinook salmon
and promotes uninhibited growth “when microinjected into fertilized, non-activated
Atlantic salmon eggs.”8 Normally, salmon stop growing once they get to a certain size,
because they have trouble swimming back upstream if they are not streamlined.9 But
Chinook salmon spawns in deeper and larger waters than other salmon species, and they
return upriver less often than other salmon species. Thus their thyroid (the growth
facilitator) allows them to grow to much larger sizes.10 When the Chinook’s growth gene
is inserted into an AAS salmon, that salmon’s thyroid will never inhibit the salmon from
growing, thus allowing it to grow to four times its normal size.11
The second gene that is added to AAS comes from the ocean pout.12 The ocean
pout has anti-freezing proteins in its blood, allowing it to live in waters close to the
freezing point.13 This gene keeps the pout’s blood thick, and it allows more of the
Chinook’s growth gene to flow through the AAS.14 Additionally, salmon naturally only
grow in the spring and summer, because the waters in which they swim in the fall and
winter are too cold to promote growth.15 The AAS with the pout’s anti-freezing gene
does not have this problem and is able to grow throughout the cold seasons.16 This again
allows the salmon to grow much faster than naturally occurring salmon are able to

US PAT 5545808, col.5 ls.8-9.
The Pacific States Marine Fisheries Commission, Chinook Salmon,
http://www.psmfc.org/habitat/edu_chinook_facts.html
10 Id.
11 Morgan, 17 OCEAN & COASTAL L.J. at 128.
12 Katherine Wilinska, 21 MINN. J. INT'L L. at 148. Not proper cite.
13 James Gorman, Dumb and Dumber: Here’s a Fish Story With Legs, N.Y. Times, September 22, 2002.
14 Morgan, 17 OCEAN & COASTAL L.J. at 128.
15 Id.
16 Id.
8
9
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grow.17 The combination of these genes allows AquaBounty’s AAS to massively outgrow
naturally fished and farmed salmon. AquaBounty’s patent application boasts that “[a]t
eight months old, the average increase of the transgenic fish was 4-fold and the largest
transgenic fish was eight times bigger than the non-transgenic controls.”18
All of this modification occurs at the zygote stage of the salmon’s development.
Thus, the salmon is allowed to develop naturally, as in nature, for the rest of its life (aside
from the fact that the development itself is not natural). In essence, the AAS is almost?
exactly the same as a naturally occurring salmon,19 save for the beneficial meddling? of
scientists in its fertilized egg.
The FDA recently decided that AAS are safe for human food production,20
although some critics have voiced concern over this decision. Despite the FDA’s
approval, some remain concerned that the salmon should not be produced for human
consumption; that the consequences to the environment of the salmon escaping would be
disastrous; and that allowing these salmon to be produced would seriously affect the
fishing industry and their place in that industry, including the export to Europe. Aside
from not allowing the salmon to be produced, these people are calling for more regulation
of genetically modified food, including requiring a consumer label to be applied to all
genetically modified food. Though arguably these might be valid concerns, this paper
will assert that the FDA should not take a larger interest in regulating genetically

Id.
US PAT 5545808, col.5 ls.13-16.
19 The only difference in the salmon is the insertion of positive genetic traits. Were the salmon to be
cognizant, they would not know they were different than other salmon. Nor would anyone be able to
tell simply by looking at them.
20 FDA, VMAC Briefing Packet, AquAdvantage Salmon,
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMe
dicineAdvisoryCommittee/UCM224762.pdf
17
18
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engineered salmon because, when raised for consumption, genetically engineered salmon
pose no substantial threat to humans or the environment.

Discussion
A. Escape and environmental impact
The first concern voiced by AquAdvantage critics is that the impact of their AAS
escaping from their tanks would be disastrous to the environment.21 These critics point to
studies by the National Academy of Sciences and the EU, which conclude that
genetically modified fish will have a higher tolerance for environmental stressors, and
they will be better equipped therefore to survive in ecosystems where they previously
were unable to thrive.22 They also attack the FDA’s safety evaluation, asserting that the
FDA was “too simplistic” in its environmental impact assessment, because “history
dictates that fish held in aquaculture facilities…[inevitably] escape.”23
Usually, the risk of escape is very legitimate, because it actually does happen.
Conventionally, far- raised fish are contained in an “open system”.24 Open systems are
connected to the ocean or stream, salt or fresh water—wherever the fish need to be
raised. Open systems are basically pens for the fish, constructed with nets designed to
keep them from going into the open waters of the ocean or stream.25 In conventional

See e.g. Kimbrell, Paige Tomaselli, A "Fisheye" Lens on the Technological Dilemma: The Specter of
Genetically Engineered Animals, 18 ANIMAL L. 75 (2011).
22 Id. at 80. Should explain EU and what its concerns are
23 Id.
24 Morgan, 17 OCEAN & COASTAL L.J. at 133.
25 Kimbrell, 18 ANIMAL L. at 77.
21
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systems, escaping fish are an inescapable conclusion, because of natural failure of the
containment, human intervention, or a host of other reasons.26
There are indeed? a few environmental problems with escaping farmed salmon,
leading to a documented decline in the salmon population because of these escapes.27 It is
an obvious proposition that when humans introduce animals into the wild that have
previously been farmed and fed, this negatively impacts the wild population of that
animal (and may likely harm the ecosystem as a whole).
Escaped fish could first impact the wild salmon population by increasing
competition for food and breeding sites.28 Second, the farmed fish are not a strong or
naturally fit as wild fish. When they escape and the two interbreed, the wild population
loses its fitness edge and becomes a weaker fish.29 Combined with more competition for
resources, the weakening wild population inevitably begins to lose its competitive edge in
the ecosystem, and the salmon numbers and nutritional value begin to decline.30 Though
inescapable, the risk of this declining wild population is considered manageable, because
the escape rate of farmed salmon is only at around 1%, allowing a low enough threshold
ro prevent substantial collateral damage.31
It is possible, however, for salmon fisheries to be subject to even greater
restrictions on their escape rate. Technology exists for the fisheries to create better
containment systems, which is exactly what AquaBounty has done with its AAS.
AquaBounty thus far has kept their fish in inland tanks to minimize the risks of their

Id.
Kimbrell, 18 ANIMAL L. at 78.
28 Id.
29 Id.
30 Id.
31 Wilinska, 21 MINN. J. INT'L L. at 163.
26
27
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salmon escaping and releasing themselves into the wild.32 Because these tanks have no
direct contact with rivers, streams, or any inlet that might lead to an ocean or wild salmon
population, AquaBounty has much greater control over their salmon and the effectiveness
of their controlled system.33
AquaBounty’s closed system has multiple redundant containment systems,
including steel screens, additional jump fences, and lethal chemicals in the escape zones
and drain areas to immediately dispose of the salmon should they happen to escape the
other redundant feaatures.34 Naturally, even with multiple redundant security systems,
there is still a chance of salmon escaping. But the only way that this could happen would
be through natural disasters35, human intervention36, or mechanical failures.37 Indeed,
even should these containment features fail, the eggs are currently being grown thousands
of miles away from the nearest salmon population, e.g. in the Panamanian highlands.fn
Thus it appears that the probability of a single fish escaping containment and travelling
thousands of nautical miles through heavily predator infested waters, mating, and
spawning with enough proficiency to cause an epidemic that would decimate large
populations of wild salmon seems so infinitesimal so as to be disregarded.38 Additionally,
this geographical containment features waters in which the salmon would not be able to
survive because of their extreme temperatures. They would also probably run into actual

Id.
Morgan, 17 OCEAN & COASTAL L.J. at 134.
34 Id.
35 Force Majeur, ??e.g. floods, tornadoes/hurricanes, earthquakes, etc.
36 E.g. negligence, theft, sabotages.
37 Id. Mechanical failures may include errors or disasters in shipping eggs or mishandling or
improper disposal of samples. There are many points along the line aside from the containment that
might be vulnerable to mistake or human error.
38 Id. Id.?? to what
32
33
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hydro-electric power plants between the salmon and the nearest wild salmon population,
further compounding the salmon’s ability to escape and do actual damage to the wild.39
Finally, critics still suppose that should the unthinkable happen, that some of the
contained salmon actually escape and insert themselves into a wild salmon population,
the results would be much more devastating than when farmed salmon escape. There is
no doubt that these genetically modified salmon would outcompete natural salmon for
resources.40 They would be bigger, faster, and would have a better ability to get at the
natural resources.41 Additionally, they would need more resources to survive because of
their size, so a single AAS would not only be replacing a single wild salmon.?? The AAS
would consume? the resources of several wild salmon to sustain itself, thereby drastically
reducing the numbers of wild salmon by sheer numbers and competition.42
Additionally, the release of AAS into the wild would most likely cause what
scientists have dubbed the “Trojan gene” effect.43 AAS would have an enhanced ability
to mate, because of their size and strength. However, AAS also have reduced viability as
adults simply because they need so many resources to survive. Thus, when the AAS
releases the Trojan gene into the wild population, each successive generation of fish
would be less viable than their parent generation.44 The salmon would become more
aggressive, would have to change their breeding patterns, and ultimately would have to
change their migration patterns, making them less successful and viable for all of these

Id.
Kimbrell, 18 Animal L. at 80.
41 Id.
42 Id.
43 Id. at 81.
44 Id.
39
40
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things.45 The less viable wild salmon population would therefore not be able to live up to
the survival of the fittest, and wiould be eventually completely destroyed.46 Some
scientists estimate that salmon could be extinct in less than 40 generations, should the
AAS allow the Trojan gene to run rampant in wild salmon populations.47 This “Trojan
gene” scenario is not the only, but is the worst scenario? that the CABI or any scientific
study has been able to postulate, and it is only a theoretical “high risk scenario” in which
the GM fish outcompetes the wild fish for reproductive opportunities, only to have far
weaker post-reproduction survival skills-leading to a collapse of entire wild stocks.”48
AquaBounty has introduced an additional redundant layer of containment into
their AAS for just this reason. Even if their AAS were able to escape and overcome the
significant odds that they would be killed before they could even come close to a wild
population, they could not reproduce, because of two reasons: All the AAS are female,
and all the AAS are sterile.49 All female AAS is a function of the genetic process that
AquaBounty uses to create the salmon. Because of the process, all the AAS are triploid.50
Because all the fish have three X chromosomes, they all must be female. The third
chromosome also renders them close to 100% sterile, because it is such a genetic
abnormality.51 Analysis has confirmed that less than 1% of all AAS are sterile, and 100%
are female.52

Kimbrell, 18 Animal L. at 82. Should use supra & proper citations.
Id.
47 Id.
48 Morgan, 17 Ocean & Coastal L.J. at 161.
49 Id. at 134.
50 Id.
51 Michael Bennett Homer, Frankenfish It's What's for Dinner: The FDA, Genetically Engineered Salmon,
and the Flawed Regulation of Biotechnology, 45 COLUM. J.L. & SOC. Probs. 83, 116 (2011).
52 Morgan, 17 OCEAN & COASTAL L.J. at 161. Should use supra citation instead of repeating title.
45
46
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Because AquaBounty has created a closed system, there is an infinitesimal chance
that the AAS will escape their containment. Because of the geographic containment
feature of containment, there is also an infinitesimal chance that if the AAS somehow
escape their facility containment they would be able to even come close to another, wild
population of salmon. Finally, because of the triploid biologic features of the fish, there is
less than a 2% chance that the fish will be sterile, and there is a 100% chance that the fish
will all be female. Combining all these probabilities, the chance of escape and survival to
endanger a natural salmon population is effectively zero, and there should be no reason to
fear any disastrous effects of what would happen if the AAS were able to escape their
containment.

B. Modified Food In General
In 2000, the Department of Agriculture did a study on all of the genetically
modified foods present in America. Their findings among other things, were that 25% of
all corn, 54% of all soybeans, and 61% of all cotton planted in the United States had been
modified in some way or another.53 However, these findings proved premature if taken to
be completely indicative of the extent? of genetically modified food sold in the United
States. The very next year, these percentages increased to 88%, 94%, and 90%,
respectively.54 Of course, this only reflects the numbers of corn, soybeans, and cotton.
Other recent estimates show that close to 75% of all processed foods that consumers
purchased in supermarkets contains genetically engineered ingredients.55 Generally, there
is no significant difference between these genetically modified productsand the

Homer, 45 COLUM. J.L. & SOC. PROBS. at 83.
Id.
55 Id.
53
54
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originals?, and only about one0in-three Americans realize the fact that most of the food
they eat has already been genetically modified.56 Genetic engineering helps to enhance
agricultural efficiency, increase the amount and ability of crops to survive and that will
survive, reduce the amount of food needed to be grown and the space that it will need to
grow, as well as many other helpful things.57 {Do we know for sure that there are no long
term effects? Doesn’t it depend to some degree about what methods and ingredients are
used to create the modification. What is put into soybeans is not the same as used to
genetically alter salmon.]
However, not everyone sees these modifications as unequivocally good things.
Some critics worry about the technological uncertainties of genetic engineering and the
effects that the foods will have not only on humans who consume them, but also the
environment in which they are grown.58 Critics fear a loss of biodiversity by extinction of
species. These arguments are much the same as arguments from those worried about the
wild salmon population being destroyed. Why are they the same? Because you think
they are groundless? They are not as forceful, however, because no one really seems to
care as much about plants as animals, and humankind has been genetically modifying
plants since we discovered that we were able to graft plants together. These critics have
asked the federal government for more regulation and oversight in the production of
genetically modified foods.59
Up to now, this kind of oversight and regulation has not been the United States’
preferred method of dealing with genetically modified foods. Consumers have been

Wilinska, 21 Minn. J. Int'l L. at 151.
See e.g. Homer, 45 COLUM. J.L. & SOC. PROBS. Improper footnotes
58 Id.
59 Id.
56
57
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traditionally more tolerant of genetic modification, assumedly for the reasons espoused
above.60 Genetically modified foods have been subjected to a lenient regulatory
framework within the United States, perhaps? because of the general approach that these
foods should not be assumed harmful until evidence is presented to the contrary.61
This approach has been referred to as “The Equivalence Principle”.62 The United
States policy regarding most new products has always had a mind toward risk.
Essentially, in US jurisprudence, [this is not jurisprudence!!] this principle assumes that if
a genetically enhanced product is essentially or substantially equivalent to its underlying,
natural product, there should be no significant adverse effect on its production or
consumption.63 The FDA’s statement of its own position reflects this: Transgenic foods
are “generally recognized as safe,” until proven otherwise.64 As scholars point out, this
more or less means that the introduction of genetically modified products into consumer
markets is controlled by free market principles.65 This allows quicker and more exact
scientific progress, and ultimately allows for better products to reach consumer markets
faster.

C. Regulation of Genetically Modified Foods
Approximately 25 percent of all consumer products marketed in the United States
are overseen and approved by the FDA.66 Congress, in enacting legislation delegating
oversight power to the FDA, has created statutorily defined classes of products that the
Wilinska, 21 MINN. J. INT'L L. at 163 (2012)
Id.
62 Id.
63 Id.
64 George Kimbrell, Paige Tomaselli, A "Fisheye" Lens on the Technological Dilemma: The Specter of
Genetically Engineered Animals, 18 Animal L. 75, 97 (2011).
65 See e.g. Wilinska, 21 MINN. J. INT'L L. at 163.
66 FDA, Advancing Regulatory Science at FDA: A Strategic Plan (2011), available at
http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm.
60
61
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FDA can regulate. Because of this approach of categorizing every consumer product
class, the legal and regulatory framework in which the FDA analyzes each new product
varies according to which statutory category that a new product will fit into.67 This means
that rather than taking oversight over the processes by which food and drugs are allowed
to enter into the market, the FDA really only takes control of the actual products
themselves. While this may have been a good approach to organizing the FDA’s
authority when the Food, Drug, and Cosmetic Act (FDCA)68 was enacted, it makes it
increasingly difficult for FDA regulations to keep up with emerging technologies and
scientific progress when it comes to new products.69
Many commentators have expressed concern with how this affects the amount of
regulation that the FDA actually has over the entrance of technologically.70 Regardless of
how valid or invalid these criticisms may be regardiing this (arguably) inflexible statutory
framework, the FDA has asserted authority over genetically modified animals under
interpretation of several statutes codified from the FDCA. 71 Additionally, the FDA has
provided explanation their own internal documents concerning administrative procedure
and authority.72 Unclear??
The FDA first has authority to regulate genetically modified animal products,
because it already regulates “new animal drugs”, whether or not these animals are used

Jordan Paradise & Ethan Fitzpatrick, Synthetic Biology: Does Re-Writing Nature Require Re-Writing
Regulation?, 117 PENN ST. L. REV. 53, 63 (2012).
68 See generally 21 U.S.C. § 301 et seq.
69 Supra Paradise, n.67. not proper cite
70 See e.g. Susan B. Foote & Robert J. Berlin, Can Regulation Be as Innovative as Science and
Technology? The FDA's Regulation of Combination Products, 6 MINN. J. L. SCI. & TECH. 619, 623 (2005).
71 71 See generally 21 U.S.C. § 301 et seq.
72 See generally e.g. FDA, Genetically Engineered Animals, http://
www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngi
neeredAnimals/ default.htm; See also A Strategic Plan, supra n.65.
67
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for human consumption.73 As defined by federal statute, new animal drugs include “any
drug intended for use for animals other than man, including any drug intended for use in
animal feed but not including such animal feed.”74 Though recombinant DNA (rDNA)
might not seem like a drug to a layperson, the process is applied to animals in the same
way as a conventional drug might be, and the FDA considers the two effectively the
same.75 Unclear
Last year, the FDA released guidance regarding this position, and in the most
relevant part stated, “an rDNA construct is in a GE animal and is intended to affect the
animal's structure or function meets the definition of an animal drug, whether the animal
is intended for food, or used to produce another substance.”76 Because the application of
rDNA is intended to affect the animal in the same way as a conventional drug, the FDA is
in charge of its regulation. The authority to regulate new animal drugs is the most
important part of the FDA’s analysis of new foods, because it allows the FDA to oversee
every part of the construction of the food, as opposed only being able to regulate the
consumer product as a whole right before it hits the market. This is very technical and
not very clear to a layperson. Footnotes could help explain it.
However, this is not the only way that the FDA can assert authority over
genetically modified animals as food. The FDA additionally has authority to regulate
genetically modified animals as human consumption because rDNA might be considered

21 U.S.C. § 321.
Id.
75 FDA, Guidance for Industry: Regulation of Genetically Engineered Animals Containing Heritable
Recombinant Constructs 4,
http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforI
ndustry/ ucm113903.pdf.
76 Id. (emphasis added).
73
74
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an adulteration to the product.77 Adulteration is defined in many ways in the statute, but
most generally, a food is considered adulterated if it “bears or contains any poisonous or
deleterious substance which may render it injurious to [public] health.”78 Foods are not
presumed adulterated so long as they comply with the conditions and guidelines of the
FDA.79 In the same report, the FDA added harsher compliance requirements for foods
modified with rDNA, requiring that “developers of these animals must demonstrate that
the construct and any new products expressed from the inserted construct are safe for the
health of the [genetically engineered] animal and, if they are food animals, for food
consumption.”80 The FDA’s authority over whether a food is adulterated allows the FDA
to regulate not only what composes or makes up the food, but also if the food will be
harmful on a higher level, as a food for general human consumption.
Once the FDA has determined that an animal applied with changed rDNA and
grown for human consumption is safe for human consumption, it must amend the
applicable regulations to reflect the specific product approved.81 Though the FDA is very
close to approving genetically modified salmon and adding regulation to that effect, the
only applicable example of this process resulting in created regulation in current law has
to do with goat milk.82 Many scholars have surmised that the next genetically modified
animal product that will be explicitly regulated will be the AquAdvantage Salmon, and

21 U.S.C. § 360b.
21 U.S.C. § 342.
79 Paradise, supra n.66 at 69.
80 Guidance for Industry, supra n.74.
81 Paradise, supra n.66 at 70.
82 21 C.F.R. § 528.1070
77
78
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after a 17 year process, the FDA’s own briefing packets suggest this statement will be
true.83
i. Specific FDA Regulation of Genetically Modified Salmon
The FDA’s specific approach to deciding whether AAS should be allowed
focuses on three different criteria: “The safety of the transgenic construct for the animal;
safety of the food from the animal; environmental impact.”84 This paper has already
discussed the environmental impact of the AAS, and the FDA reached the same
conclusion about the environmental impact as that reached above. [you said earlier that it
has not yet completed its investigation]The safety of the transgenic construct is not an
issue in this case, because there is obviously no danger to the AAS itself. The salmon
develops and lives out its life (relatively) normally in captivity, able to do everything that
a naturally occurring, wild salmon would.?? Is it really the same? Additionally, even if
the safety of the transgenic construct used in creating AAS were at issue, the FDA has
already asserted its regulatory authority over the product and determined it completely
safe.85
Then the only remaining issue is for the FDA to determine the safety of the food
gained from the animal. The equivalency principle lends itself very well to this analysis.86
AquaBounty does meddle in the genetic process of the salmon. However, the scientific
interference with the salmon’s natural processes does not last for longer than the zygote
stage of its development. After that stage, AquaBounty’s only contact with their salmon
See FDA, VMAC Briefing Packet, AquAdvantage Salmon,
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMe
dicineAdvisoryCommittee/UCM224762.pdf
84 Id.
85 As discussed supra in the preceding paragraphs
86 Contra Kimbrell, 18 ANIMAL L. at 97.
83
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is generally to feed it and make sure that they remain captive and do not interfere with
any population of wild salmon. AAS feed normally, and they do everything that other
salmon do naturally in the wild, aside from reproduce. While this somewhat destroys the
salmon’s majestic story, it does nothing to detrimentally impact ? their nutritional value.
In fact, it only enhances the good nutritional qualities of naturally occurring salmon,
without enhancing any of the drawbacks. This obviously passes the FDA’s second
concern in its test, and after assuring that there is no adverse environmental impact, the
FDA has no reason to block or otherwise restrict this kind of salmon production.
The FDA’s approval method and general attitude towards this type of production
in the United States can be contrasted with the European Union’s approach to genetically
modified products in the marketplace. Historically, the European public has not been as
accepting of genetically modified foods, sparking huge debate and resistance.87 European
consumers do not believe that genetically modified foods will be safe; and, even if they
are safe, the consumers do not believe that their government can adequately control or
oversee genetic modification or production.88
ii. European Union Regulation of Genetically Modified Food
This public concern? has led to a different kind of principle governing European
legislation: The Precautionary Principle.89 This is the complete opposite of the United
States’ stance. Using the precautionary principle, genetically modified food is considered
unsafe until it can be effectively proven that there are no risks involved.90 Any applicant

Wilinska, 21 MINN. J. INT'L L. at 163.
Valery Federici, Genetically Modified Food and Informed Consumer Choice: Comparing U.S. and E.U.
Labeling Laws, 35 BROOK. J. INT'L L. 515, 538 (2010).
89 Wilinska, 21 MINN. J. INT'L L., at 163.
90 See generally PARL. EUR. DOC. (Reg. 1829/2003).
87
88
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seekingto produce genetically modified food must convince? the European Union that the
product will be safe before it can even be marketed, based on part by an independent
assessment from a third party of the food’s possible risks and rewards.91 This third party
would be whatever “national competent authority” that each country might recognize as
their own administrative body (comparable to the US’s FDA).92 Any producer trying to
sell its genetically modified products in the European Union must not only comply with
EU regulations. Additionally, producers must comply with their own national standards,
which might even be harsher than EU regulation. EU regulation of the application itself is
extensive, applying a heavy burden on the producer to show that its product is safe.93 The
applicant must not only provide convincing details as to how the genetically modified
food was created, stored, raised, etc.; but, also, details as to other possible concerns, such
as inclusion of a “reasoned statement that the food does not give rise to ethical or
religious concerns.”94 This provision alone would seem to an extremely high hurdle for
genetically modified food to jump, as many religions are highly skeptical of genetic
modification in the first place.fn? How do you know this? Naturally, the European
Union’s stricter approach mandates much slower growth and innovation in the
marketplace, and ultimately such stricter regulation makes it much harder for the
modified food industry to flourish.95

See 2001 O.J. L. 106 17.04; see also 2004 O.J. L. 102 07.04.
PARL. EUR. DOC. (Reg. 1829/2003) Art.4, Sec2(a)(i) et seq.
93 Id.
94 Id. Art.4, Sec. 3(g).
95 The instant subject of this entire paper may be a good example of the veracity of this statement, as
a European biotech company has invested a huge amount of time and money only into developing the
product for a US marketplace. GOOD. Who is it? More could/should be said about it.
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The main difference between US and EU legislation has to do with the labeling of
genetically modified foods.96 The United States does not impose labeling requirements on
any distributor of genetically modified foods.97 The FDA has released voluntary
guidelines, however,; but there is no reason for any food distributor to worry? about
following these guidelines, save for consumer expectation.98 Taken with the fact that only
1/3 of the population even knows about genetic modification of foods such as corn, there
is really no need for companies to develop marketing plans to deal with consumer
expectation or disapproval. This undoubtedly applies to AAS as well, as it is a genetically
modified food. As discussed above, the FDA has assumed sole responsibility of
regulating genetically modified animal food, and has green-lighted AAS for human
consumption without a need for labeling.99 The European Union has much stricter
labeling restrictions, requiring mandatory product labeling and ultimate transparency to
the consumer, as well as government monitoring and public disclosure of the growing
process.100 These stricter restrictions apply to any foods imported to the EU as well.101 In
fact, the vast bulk of the EU regulations regarding genetically modified foods speak of
labeling in some way or another, as most provisions include the phrase: “or a proposal
for labeling [sic] the food in accordance with Article…”102 [Is there some evidence that
EU consumers care more about possible safety issues? Has anyone tried to explain why
the EU is so cautious?]

Federici, supra n.90.
Wilinska, 21 MINN. J. INT'L L. at 163.
98 Id.
99 Homer, 45 COLUM. J.L. & SOC. PROBS. at 83.
100 Wilinska, 21 MINN. J. INT'L L. at 163.
101 Id.
102 See e.g. PARL. EUR. DOC. (Reg. 1829/2003) Art.4, Sec 3(f), (g), etc.
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iii. United States Accommodation of European Union Guidelines
The discrepancy between labeling may very well affect the import/export salmon
market in the EU. Currently, 23% of the US’s salmon production is exported to the
EU.103 Should AAS begin to take over a significant portion of the salmon market, the EU
may stop buying US salmon, due to its fear of receiving a product that it deems as unsafe
because of failure to follow its labeling guidelines. [US companies can follow EU
guidelines if they want to]The EU has already indicated that it would be very strict in its
application of its regulations of international? movement of genetically modified
organisms.104 For various reasons,105 including fear of human safety and the continued
threat of a loss of biodiversity, the EU has implemented an expansive regulation
regarding the import and export of genetically modified organisms. This has purportedly
been done in an attempt to satisfy the Cartagena Protocol on Biosafety to the Convention
on Biological Diversity.106 Not surprisingly, the United States is not a party to this
Convention.
However, because of the fear of losing market viability, several senators have
criticized the FDA’s process of approving genetically modified foods and have tried to
change the way that the process is completed, calling for stricter guidelines and labeling
requirements.107 Scholars have also asserted that the gap between the US and EU concept

Wilinska, 21 MINN. J. INT'L L. at 163.
See 2003 O.J. L. 287.
105 See e.g. PARL. EUR. DOC. (Reg. 1946/2003) (4), (5), etc. (“It is important to organise the supervision
and control of transboundary movements of GMOs in order to contribute to ensuring the
conservation and sustainable use of biological diversity, taking also into account risks to human
health, and so as to enable citizens to make a free and informed choice in regard to GMOs”).
106 Id.
107 Wilinska, 21 MINN. J. INT'L L. at 163; Obviously, these senators are trying to change the guidelines
to something similar to those used in EU regulation.
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will widen and that the EU will ban any import of AAS into its territory.108 This should
not be a legitimate reason for the US to consider legislation to accommodate the
European Union. First, Europeans would not be afraid to buy traditional, Alaskan fished
wild or farmed salmon. Voluntary labeling from Alaskan fisheries might very well be
able to recapture the 23% market share of the European Union, mitigating? their
declining market-share from needing to compete with AAS. Second, aside from creating
a solution that would help out traditional Alaskan fisheries, continuing the policy of? not
requiring labeling will remain more in line with domestic consumers’ expectations and
the American risk assessment and efficiency model. There appears to be no reason to
start a panic among consumers that might adversely affect the salmon industry, not to
mention that such a panic would be started out of fear of losing more fickle? Or
cautious?, foreign consumers. There is no reason to force our domestic consumers to bow
to the needs of the European Union or the World Trade Organization. For obvious
reasons, if Europeans are so frightened of our products that they feel obligated to ban
their import, the EU should be and remains completely free to fish for their own salmon.
Only in very grave circumstances should we in the US? allow the European system to
dictate that our government impose unneeded restrictions and sanctions on domestic
consumers and producers. Again, since there is no evidence of harm by the salmon to
contradict the need for no further regulation, the free market is most likely the best judge
of how the European consumers and American producers should act—not the meddling
of a clearly imperfect international politic.
An interesting aside that provides supplemental evidence on this point is the fact
that AquaBounty is an English company, listed on the London Stock Exchange’s
108
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Alternative Investment Market.109 However, it is currently marketing and testing its
salmon exclusively for United States consumers. Additionally, the company has applied
for a US patent and is currently headquartered in Massachusetts.110 AquaBounty will not
even attempt to market its product in the European Union, despite being listed on their
stock exchange. Should the AAS turn out to be a superior product than natural salmon,
this would simply be a predictable byproduct of the principle of equivalence’s ability to
better adapt a product to a marketplace.

AquaBounty Technologies, The Company, http://www.aquabounty.com/company/companyhistory-292.aspx.
110 Id.
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Conclusion
With the advent of genetic technology, new and exciting possibilities are opening
up for humanity. Scholars and experts have always questioned and should always
continue to question the direction that this technology is taking us. But while
governmental involvement and regulation is a good thing, it should be limited to what is
absolutely necessary. Unlike the current policy of the European Union, governmental
intrusion should not limit the productivity or availability of products in the marketplace
more than might be absolutely necessary.
AquaBounty’s salmon has been genetically modified to grow bigger and stronger
than naturally occurring wild or farmed salmon ever will. Plus, the AquAdvantage
salmon grow at over twice the rate of naturally occurring salmon. The FDA has
extensively reviewed and recently approved the AquAdvantage salmon as safe for human
consumption, after assessing their potential impact on the environment and the safety of
the salmon to be consumed. The FDA’s review of the environmental impact has show
that there was an infinitesimal chance that the salmon would escape into the wild and
ravage natural salmon populations. Additionally, because there is no real difference
between the AquAdvantage salmon and naturally occurring salmon, the FDA has
determined that there is no reason to fear its open sale on the market.
The FDA has also put forth voluntary labeling guidelines for those that wish to
represent whether their salmon has or has not been genetically modified. Unless there is a
huge consumer outcry against genetically modified salmon, this minimal regulation
should be able to provide enough security and oversight to protect consumer choices.

Stiers
There is no need for more restrictions and regulations to save consumers or to bring
United States policy into line with the European Union’s more cautious, draconian
regulation. Because genetically modified salmon has proven safe for human consumption
and has virtually no negative impact on the environment, the FDA’s current regulation
and approach is sufficient, and there is no need for anything additional.

Better than original. Still a little one-sided. Aren’t their some scientists who may argue
that we won’t know the full effect on human safety until there has been some long-term
studies regarding the well-being of both the salmon and human consumers.?
Have their been any examples where the US approach—allow until harm is shown—has
proven disastrous? [How about some of the pills/drugs the FDA has allowed on the
marker. Also there is a chance that a company such as Aqua may fake/skew reported
findings so as to obtain approval]
Final Grade: A-

